Company intelligence / Profile preview
Jiangxi Jimin Kexin Group
Nanchang, Jiangxi, Chinajmkx.com ↗
- Ownership
- Private
- Employees
- ~12000
- Development stage
- Other
01
Overview
Jiangxi Jimin Kexin Group is one of China's largest private pharmaceutical groups, with over 12,000 employees and annual revenues exceeding RMB 17.6 billion as of 2015. It operates across R&D, manufacturing, sales/distribution of pharmaceuticals (including both small molecules and biologics), with products exported internationally. The group has made significant investments through M&A to expand its footprint across China and abroad. Subsidiaries have engaged in licensing deals for innovative drug delivery technologies (e.g., NanoZolid®) targeting prostate cancer therapy.
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
LIDDS AB (Sweden): Licensing agreement for NanoZolid® technology/Liproca® Depot for prostate cancer therapy via spinout subsidiary Jiangxi Puheng Pharmaceuticals
Beyond the preview
Go deeper on Jiangxi Jimin Kexin Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangxi Jimin Kexin Group.